Finance

Beta
Lists
GANX:NASDAQ
Gain Therapeutics Inc
$1.98
+13.14%
(+0.23) 1D
$2.39
+20.69% (+0.41)
After hours
Closed: Jun 29, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for GANX...
Open
$1.75
High
$1.99
Low
$1.75
Mkt. cap
84.46M
Avg. vol.
646.92K
Volume
5.33M
52-wk high
$4.34
52-wk low
$1.41
EPS
-$0.60
Beta
0.16
Shares outstanding
42.65M
No. of employees
21
Open
$1.75
High
$1.99
Low
$1.75
Mkt. cap
84.46M
Avg. vol.
646.92K
Volume
5.33M
52-wk high
$4.34
52-wk low
$1.41
EPS
-$0.60
Beta
0.16
Shares outstanding
42.65M
No. of employees
21
News stories
From sources across the web
About Gain Therapeutics Inc
CEO-
Employees21
Founded2017
Headquarters-
SectorBiotechnology
Websitegaintherapeutics.com
Analyst ratings
Based on 5 analysts giving stock ratings to GANX in the past 3 months
Strong buy
Buy
5
Hold
0
Sell
0
12-month forecast
Based on 5 Wall Street analysts offering 12 month price targets for GANX in the last 3 months.
Highest
Current $1.98
$8.00 (+304.04%)
Average
$7.20 (+263.64%)
Lowest
$5.00 (+152.53%)
Analyst
Recommendation
Action
Price target
Projected
Date
Ram Selvaraju
H.C. Wainwright
Buy
Reiterated
$8.00
+304%
06/08/2026
Boobalan Pachaiyappan
Roth MKM
Buy
Reiterated
$8.00
+304%
05/27/2026
Thomas Shrader
BTIG
Buy
Maintained
$5.00
+152.5%
05/26/2026
Jason McCarthy
Maxim Group
Buy
Maintained
$7.00
+253.5%
05/13/2026
Unknown Analyst
Oppenheimer
Buy
Reiterated
$8.00
+304%
05/13/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
-
Cost of goods sold
2.72M
2.81M
2.32M
2.74M
Cost of revenue
2.72M
2.81M
2.32M
2.74M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2.37M
1.98M
2.15M
2.61M
Operating expense
2.37M
1.98M
2.15M
2.61M
Total operating expenses
5.09M
4.79M
4.47M
5.35M
Operating income
-5.09M
-4.79M
-4.47M
-5.35M
Other non operating income
-
-
-
-
EBT including unusual items
-5.67M
-4.74M
-4.47M
-5.43M
EBT excluding unusual items
-5.67M
-4.74M
-4.47M
-5.43M
Income tax expense
141.20K
549.29K
70.12K
183.07K
Effective tax rate
-2.49%
-11.60%
-1.57%
-3.37%
Other operating expenses
-
-
-
-
Net income
-5.81M
-5.28M
-4.54M
-5.61M
Net profit margin
-
-
-
-
Earnings per share
-0.19
-0.15
-0.11
-0.13
Interest and investment income
47.64K
83.30K
88.58K
93.34K
Interest expense
-
-
-
-
Net interest expenses
47.64K
83.30K
88.58K
93.34K
Depreciation and amortization charges
-
-
-
-
EBITDA
-5.09M
-4.78M
-4.46M
-5.34M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer